BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Semmler G, Stift J, Scheiner B, Wöran K, Schwabl P, Paternostro R, Bucsics T, Stättermayer AF, Pinter M, Ferlitsch A, Trauner M, Reiberger T, Mandorfer M. Performance of Controlled Attenuation Parameter in Patients with Advanced Chronic Liver Disease and Portal Hypertension. Dig Dis Sci 2019;64:3642-51. [PMID: 31209721 DOI: 10.1007/s10620-019-05702-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 . MUW researcher of the month. Wien Klin Wochenschr 2021;133:994-5. [PMID: 34524539 DOI: 10.1007/s00508-021-01951-7] [Reference Citation Analysis]
2 Semmler G, Binter T, Kozbial K, Schwabl P, Chromy D, Bauer D, Simbrunner B, Müllner-Bucsics T, Scheiner B, Stättermayer A, Pinter M, Steindl-Munda P, Trauner M, Ferenci P, Reiberger T, Mandorfer M. Influence of Genetic Variants on Disease Regression and Outcomes in HCV-Related Advanced Chronic Liver Disease after SVR. J Pers Med 2021;11:281. [PMID: 33917196 DOI: 10.3390/jpm11040281] [Reference Citation Analysis]
3 Semmler G, Scheiner B, Schwabl P, Bucsics T, Paternostro R, Chromy D, Stättermayer AF, Trauner M, Mandorfer M, Ferlitsch A, Reiberger T. The impact of hepatic steatosis on portal hypertension. PLoS One 2019;14:e0224506. [PMID: 31693695 DOI: 10.1371/journal.pone.0224506] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
4 Lorenz B, Georg S, Hannes O, Stephan Z, Michael S, Leonora D, David N, Alexandra F, Felix S, Christian D, Bernhard P, Elmar A. PNPLA3 is the dominant SNP linked to liver disease severity at time of first referral to a tertiary center. Dig Liver Dis 2021:S1590-8658(21)00331-5. [PMID: 34261618 DOI: 10.1016/j.dld.2021.06.015] [Reference Citation Analysis]
5 Semmler G, Wöran K, Scheiner B, Unger LW, Paternostro R, Stift J, Schwabl P, Bucsics T, Bauer D, Simbrunner B, Stättermayer AF, Pinter M, Trauner M, Reiberger T, Mandorfer M. Novel reliability criteria for controlled attenuation parameter assessments for non-invasive evaluation of hepatic steatosis. United European Gastroenterol J 2020;8:321-31. [PMID: 32213023 DOI: 10.1177/2050640619900820] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
6 Mendoza Y, Cocciolillo S, Murgia G, Chen T, Margini C, Sebastiani G, Berzigotti A. Noninvasive Markers of Portal Hypertension Detect Decompensation in Overweight or Obese Patients With Compensated Advanced Chronic Liver Disease. Clinical Gastroenterology and Hepatology 2020;18:3017-3025.e6. [DOI: 10.1016/j.cgh.2020.04.018] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
7 Chuah K, Chan W. Quantification of Liver Fat in NAFLD: Available Modalities and Clinical Significance. Curr Hepatology Rep 2019;18:492-502. [DOI: 10.1007/s11901-019-00493-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]